AXON PAIN CLINICS LIMITED
Opportunity 65/100 (strong), bankability 50/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: File overdue accounts. Clears statutory overdue flag — immediate bankability uplift for refinance conversations. Most likely exit: share sale to pe / searcher (53/100).
Data confidence
Overall: medium (72/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2024-03-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
Corporate timeline (12 events)Click to expand
- 2024-12-18📄accounts-with-accounts-type-dormantaccounts · AA
- 2024-10-22📄change-person-director-company-with-change-dateofficers · CH01
- 2024-10-21📄change-person-director-company-with-change-dateofficers · CH01
- 2024-10-21📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-10-21📄change-person-director-company-with-change-dateofficers · CH01
- 2024-03-15📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2024-02-29📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2024-02-29📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2024-02-29📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2023-09-12🏢Company incorporatedAs AXON PAIN CLINICS LIMITED
- 2023-09-12➕LITTLE, Richard appointeddirector
- 2023-09-12📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Senior director age: Director aged approximately 60 — approaching natural succession window.
- +Young company: Only 2.6 years old — management layer unlikely to be developed.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- secondaryFounder aged 58+: Senior director is approximately 60. Early succession window.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
1 high ·Statutory accounts have not been filed by their due date. Can indicate admin breakdown, cash preservation, or deliberate delay.
Evidence: Next due: 2026-03-31
Group structure
Exsurgo Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Exsurgo Limited Corporate entity | 75–100% | — | 75-100% shares | 29/02/2024 |
1 historic (ceased) PSC
- Mr Richard Littleceased 29/02/2024· 75-100% shares · 75-100% voting · board control
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AR DENTAL LIMITED→ SC400032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ARDPEATON LIMITED→ SC780810 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ARICOM SATELLITE LIMITED→ SC678887 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ARRAN PHARMACY LIMITED→ SC222920 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| ASHPHARM GLASGOW LTD→ SC628555 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AURORA WOMEN'S MEDICAL LTD→ SC881744 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AVISTAR MEDICAL LTD→ SC864683 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AWSC LIMITED→ SC636346 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AYMAN & MARTIN LIMITED→ SC723846 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AYPLUS MEDICS LIMITED→ SC792280 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AYR CARE LTD→ SC665188 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AYRSHIRE PRIVATE HEALTHCARE LTD→ SC733528 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
10 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.